IDH2 gene expression was found significantly downregulated in early stage (in situ carcinoma) but upregulated in advanced stage (infiltrating carcinoma) colorectal cancer (CRC) compared to peritumor tissue. This evidence concerns the gene IDH2 and colorectal carcinoma.